Sci Simple

New Science Research Articles Everyday

# Health Sciences # Neurology

Understanding Long COVID and Its Effects

Long COVID brings ongoing health issues for many after initial infection.

Michael R. Lawrence, Judith E. Arnetz, Scott E. Counts, Aiesha Ahmed, Bengt B. Arnetz

― 7 min read


Long COVID: A Lingering Long COVID: A Lingering Issue Long COVID patients. Exploring ongoing challenges faced by
Table of Contents

Long COVID, also known as post COVID conditions (PCC), is a term used to describe ongoing health issues that some people face after recovering from the initial COVID-19 infection. Think of it as the annoying guest who doesn’t leave after the party is over. While many people recover quickly, around 30% of those who had COVID-19 experience lingering symptoms that can last for months or even years.

The Symptoms

So, what do folks dealing with Long COVID experience? Symptoms can vary a lot, but many people report feeling mentally cloudy. You know that moment when you walk into a room and forget why you went in there? Well, for some, that feeling becomes a daily occurrence. This is often referred to as "brain fog."

In addition to brain fog, some report having trouble remembering things or staying focused. It’s like trying to watch your favorite show with constant buffering – frustrating and annoying! Other symptoms may include fatigue, anxiety, and depression, which can feel like trying to climb a slippery slope.

Who is Affected?

Interestingly, research has shown that even people who had mild COVID-19 infections can experience these ongoing issues. And if someone had cognitive problems before getting sick, they might find those issues worsen afterward. It’s almost like COVID-19 brought along a surprise baggage claim of problems.

Surveys and Findings

Several surveys have looked into Long COVID and its effects. One large survey conducted during 2021-2022 found that about 46% of people who reported Long COVID experienced brain fog or memory issues. Imagine trying to work full-time while feeling like you’re constantly stuck in a thick fog. Not ideal, right?

Another study revealed that about 57% of individuals with Long COVID had more frequent cognitive problems than those who recovered without any post-COVID conditions. Brain fog and difficulties with attention and memory were common among 40-60% of those affected.

But here’s a twist: even though many reported cognitive complaints, studies of cognitive testing haven’t shown significant deficits. It’s like saying, "I feel like I’m creeping through molasses," but tests say, "Nope, you’re just fine!"

Cognitive Tests and Surprising Results

In studies involving Long COVID, individuals might perform well on cognitive tests, even while feeling like their brains are in a slow-motion reel. For example, one study found that people with cognitive complaints scored within the normal range on certain tests. However, without a comparison group, it’s hard to say how valid that really is.

In another study, when they looked at Long COVID patients with cognitive complaints compared to healthy controls, the ones who felt "foggy" scored worse in areas like memory and processing speed. So, while tests might say one thing, those living with the condition often report a different story.

The Mystery of Biomarkers

Many researchers are trying to figure out what’s happening in the body of someone with Long COVID. One way to do this is through biomarkers, which are like tiny messengers in the body that can give clues about health. Some studies have found potential biomarkers related to Inflammation and neuroplasticity (the brain's ability to adapt and change).

Different studies have pointed to various inflammatory markers that seem to be higher in Long COVID patients. However, the results are still somewhat mixed, making it tricky to pinpoint the exact cause of these cognitive issues. It’s a bit like trying to find Waldo in a crowded picture – there are a lot of characters, but you’re not quite sure which one is the real culprit.

What Did Our Pilot Study Do?

To dig deeper, a small pilot study was conducted looking at two groups of people who had confirmed COVID-19 infections: those still experiencing cognitive symptoms and those fully recovered. A total of 17 participants took part in this study, and researchers were keen to compare their cognitive performance, emotional health, and biomarkers related to stress and inflammation.

Participants were given various tests and looked at their blood samples for clues. They also reported on their quality of life and self-rated health. After all, how someone feels about their health can sometimes be more telling than any number on a test.

Who Participated?

Participants ranged from ages 25 to 65 and were recruited from health facilities in Michigan. They fell into two groups based on whether they were experiencing cognitive symptoms or had fully recovered without any lingering issues. Efforts were made to match participants for age and sex, although the sample ended up being mostly female and White.

What Did They Find?

Self-Report Measures

When it came to self-reported measures regarding mood and quality of life, those with Long COVID reported feeling worse off compared to the control group. They said they felt more pain, discomfort, and limitations in their daily activities. Think of it as running a race but with one shoe tied together – it’s a struggle!

On emotional health, the Long COVID group reported higher levels of anxiety and depression. It’s tough to feel on top of the world when you’re stuck in the fog.

Cognitive Testing Results

Despite the self-reporting, when it came to cognitive tests, no significant differences were observed among most tasks. The only standout was in language-related tasks, where the Long COVID group struggled more with verbal fluency. This suggests that while they might feel foggy and unable to think clearly, they might still ace some of the testing.

Looking at Biomarkers

In terms of blood samples, researchers found some interesting patterns. One particular marker, nerve growth factor (NGF), was lower in the Long COVID group. NGF plays a role in nerve growth and health, and its lower levels might mean the brain isn’t quite as resilient as it should be.

When looking at inflammatory markers, the Long COVID group showed higher levels of certain indicators compared to the control group. This suggests there might be some ongoing inflammatory processes that need attention.

The Bigger Picture

The findings from this pilot study suggest that even though Long COVID patients might perform well in cognitive tests, they still face challenges in daily life, emotional well-being, and self-rated health. This raises questions about how we understand and treat Long COVID.

Are there ways to help those experiencing brain fog regain clarity? Could techniques like cognitive therapy or specific interventions targeting inflammation help improve quality of life?

As the research continues, it’s clear that we need to take Long COVID seriously and consider a comprehensive, multidisciplinary approach to treatment. After all, living in a fog can be hard, but with the right help and understanding, there’s hope for clearer skies ahead.

What Can Be Done?

  1. Awareness: Create awareness about Long COVID and its symptoms so that those suffering can receive proper support.

  2. Mental Health Support: Incorporate mental health care into recovery plans for those dealing with anxiety and depression.

  3. Holistic Treatment: Use a combination of treatments that address cognitive, emotional, and physical health.

  4. Longitudinal Studies: As more research is needed, it’s vital to follow patients long-term to see how their health changes. Large studies can provide a clearer picture of what’s happening.

  5. Involvement of Patients: Engage with patients to hear their experiences and needs. They often know what works or doesn’t work best for them.

Conclusion

Long COVID is a complicated condition that can affect various aspects of life, particularly cognitive function. While many find themselves managing their symptoms without clear solutions, ongoing research is essential to uncover the underlying causes and develop effective treatments. In the meantime, supporting those affected by Long COVID is crucial, ensuring they have access to the resources and care they need to navigate through the fog.

So, if you’re feeling a bit "foggy," know you’re not alone; there’s a whole community working to understand and alleviate these challenges. Together, hopefully, we can figure out how to clear the air and let the sunshine back in!

Original Source

Title: Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: a pilot study

Abstract: ObjectiveSubstantial numbers of individuals who contract COVID-19 experience long-lasting cognitive symptoms such as brain fog. Yet research to date has not compared these patients with healthy controls with a history of laboratory-confirmed COVID-19 infection, making it difficult to understand why certain COVID patients develop post-COVID cognitive symptoms while others do not. The objective of this pilot study was to compare two groups of laboratory-confirmed post-COVID patients, with and without cognitive symptoms, on measures of cognitive and psychological functioning, self-reported perceptions of functional status and quality of life, and biomarkers of stress, inflammation, and neuroplasticity. MethodsUsing a case-control design, 17 participants were recruited from a healthcare system in western Michigan, USA in 2022 through 2024. All participants were aged 25-65 and had a positive polymerase chain reaction (PCR) test confirming previous COVID-19 infection. Ten participants reported cognitive symptoms (long COVID group) while seven were fully recovered with no residual symptoms (controls). All participants underwent an interview on their self-rated health and quality of life, a battery of neurocognitive tests, and blood draw for biomarker analysis. ResultsNo group differences were detected for neuropsychological test measures except for letter fluency where the long COVID group scored significantly lower (p

Authors: Michael R. Lawrence, Judith E. Arnetz, Scott E. Counts, Aiesha Ahmed, Bengt B. Arnetz

Last Update: 2024-11-29 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.11.28.24318139

Source PDF: https://www.medrxiv.org/content/10.1101/2024.11.28.24318139.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

Similar Articles